Stay updated with breaking news from Athogen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.
The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.
A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.
Study demonstrated how phage can be engineered to produce bacteriocins and cell wall hydrolases as antimicrobial effector genes.
A group of authors summarized adjuvant mechanisms, characteristics, and applications, seeking to overcome current vaccine limitations.